NASDAQ:AMPH   Amphastar Pharmaceuticals, Inc.
After a deep pullback in August and September, Amphastar is coming back in a big way. Following its early-November earnings report, the stock is up more than 20% in the last few weeks. It has reclaimed all its moving averages and is now consolidation with a pivot at $58.

Volume has dried up nicely during this consolidation which is typically a sign the stock is becoming harder to buy and getting concentrated into strong institutional hands.

One might consider buying on a high-volume move above $58.

Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.